tiprankstipranks
Trending News
More News >
Lineage Cell Therapeutics, Inc. (LCTX)
:LCTX

Compare Lineage Therap (LCTX) vs. Competitors

Compare
2,047 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Lineage Therap
$1.45
$361.18M
-6.05
190.00%
2 Buy
0 Hold
0 Sell
Moderate Buy
Amarin
$14.49
$301.55M
-149.32
66.36%
0 Buy
0 Hold
1 Sell
Moderate Sell
Tvardi Therapeutics
$3.52
$33.02M
-16.53
-77.22%
2 Buy
0 Hold
0 Sell
Moderate Buy
DBV Technologies SA - American
$19.09
$1.10B
-1.46
261.55%
2 Buy
0 Hold
0 Sell
Moderate Buy
4D Molecular Therapeutics
$8.61
$439.55M
-3.10
129.60%
6 Buy
2 Hold
0 Sell
Strong Buy
Aura Biosciences Inc
$5.51
$415.95M
-3.90
-11.73%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
LCTX
Lineage Therap
1.45
0.91
170.52%
AMRN
Amarin
14.49
5.20
55.97%
TVRD
Tvardi Therapeutics
3.52
-13.34
-79.12%
DBVT
DBV Technologies SA - American
19.09
14.63
328.03%
FDMT
4D Molecular Therapeutics
8.61
4.68
119.08%
AURA
Aura Biosciences Inc
6.55
-0.45
-6.43%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts